SISTEMAS GENOMICOS SL

Their core work

Sistemas Genómicos is a Spanish genomics and molecular diagnostics company that provides DNA/RNA sequencing, bioinformatics analysis, and omics-based services. They apply their genomic expertise across both human health (cancer diagnostics via liquid biopsy) and agricultural genomics (berry crop improvement through systems biology). Their core business is offering high-throughput sequencing and genomic data analysis as a specialized service to research consortia and clinical projects.

What they specialise in

How they've shifted over time

All three H2020 projects launched in 2016, making it difficult to identify a clear temporal evolution. However, the project portfolio reveals a company applying a single core competency — genomics and omics analysis — across increasingly diverse application domains, from cancer diagnostics to agricultural systems biology. The GoodBerry project (their largest by funding, running to 2020) suggests growing engagement with agricultural genomics and climate adaptation research.

Their largest and longest-running project was in agricultural genomics, suggesting potential deepening interest in applying omics to food and climate challenges alongside their health diagnostics work.

How they like to work

Sistemas Genómicos operates exclusively as a participant, never leading consortia — consistent with their role as a specialized service provider contributing genomics expertise to larger projects. With 37 unique partners across 12 countries from just 3 projects, they integrate into large, diverse European consortia rather than working in small focused teams. This profile suggests a reliable technical contributor that consortium coordinators can plug in for sequencing and bioinformatics work.

Despite only three projects, they have built a broad network of 37 partners across 12 countries, reflecting participation in large multi-national consortia spanning health and agriculture sectors across Europe.

What sets them apart

Their distinctive value lies in being a private genomics SME that bridges human health and agricultural applications — most genomics companies specialize in one domain. Based in the Valencia biotech cluster (Paterna), they offer commercial-grade sequencing services with the flexibility of an SME. For consortium builders, they fill the "genomics service provider" slot with demonstrated experience in both clinical and crop science contexts.

Highlights from their portfolio

• GoodBerry
  Their largest project (€302K) applying omic approaches and systems biology to berry crop improvement under climate change — their most substantial H2020 engagement.
• Liqbiopsens
  Focused on liquid biopsy for early colorectal cancer detection, demonstrating their capabilities in clinical molecular diagnostics and biomarker analysis.